[Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis]

G Chir. 2004 Jan-Feb;25(1-2):43-6.
[Article in Italian]

Abstract

The association between chemotherapy and hypertermia produces a synergic effect. In this study the Authors present their experience, by the analysis of the results. From 1993 to 2000, 17 patients have been treated with surgery associated with hypertermic chemotherapy for peritoneal carcinomatosis. For the management of these patients a constant cooperation among surgeon, cardiologist and anaesthetist is very important.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Appendiceal Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Carcinoid Tumor / secondary
  • Carcinoma / drug therapy
  • Carcinoma / secondary*
  • Carcinoma / surgery
  • Carcinoma / therapy
  • Carcinoma, Ductal, Breast / surgery
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / physiopathology
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Colonic Neoplasms / pathology
  • Combined Modality Therapy
  • Female
  • Humans
  • Hyperthermia, Induced / adverse effects*
  • Male
  • Middle Aged
  • Neoplasm Seeding
  • Neoplasms, Second Primary
  • Ovarian Neoplasms / pathology
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / secondary*
  • Peritoneal Neoplasms / surgery
  • Peritoneal Neoplasms / therapy
  • Retrospective Studies
  • Stomach Neoplasms / pathology
  • Treatment Outcome

Substances

  • Cisplatin